Author:
Copland M.,Fraser A. R.,Harrison S. J.,Holyoake T. L.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference97 articles.
1. Appel S, Boehmler AM, Grunebach F, Muller MR, Rupf A, Weck MM, Hartmann U, Reichardt VL, Kanz L, Brummendorf TH, Brossart P (2004) Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells. Blood 103:538?544
2. Avery S, Nadal E, Davis J, Apperley J, Goldman J, Marin D (2003) Infusion of peripheral blood stem cells collected at diagnosis can improve the level of cytogenetic response in CML patients on imatinib whose treatment is limited by cytopaenia. Blood 102:318b
3. Bakalova R, Ohba H, Zhelev Z, Ishikawa M, Shinohara Y, Baba Y (2003) Cross-talk between Bcr-Abl tyrosine kinase, protein kinase C and telomerase-a potential reason for resistance to Glivec in chronic myelogenous leukaemia. Biochem Pharmacol 66:1879?1884
4. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245?252
5. Barrett AJ, van Rhee F (1997) Graft-versus-leukaemia. Baillieres Clin Haematol 10:337?355
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献